44
Views
0
CrossRef citations to date
0
Altmetric
Corrigendum

Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin’s lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey [Corrigendum]

Page 75 | Published online: 17 Jan 2017